查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786532

週边药物释放型球囊市场：全球产业分析、规模、份额、成长、趋势及预测（2025-2032）

Peripheral Drug Eluting Balloon Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 273 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球週边药物释放型球囊市场的综合研究报告，该报告全面评估了关键市场动态，包括市场驱动因素、趋势、挑战，并对市场结构提供了详细的见解。

关键见解

  • 週边药物释放型球囊市场规模（2025年）：10.352亿美元
  • 市场预测（2032 年）：18.443 亿美元
  • 全球市场成长率（2025-2032年复合年增长率）：8.6%

週边药物释放型球囊市场 - 范围

週边药物释放型球囊 (DEB) 是一种用于治疗周边动脉疾病(PAD)的医疗设备，透过在血管成形术中将抗血管再阻塞药物直接输送至动脉壁。 DEB 结合了球囊血管成形术的机械优势和药物输送的药理优势，降低了血管再阻塞的发生率，并无需永久性植入。此市场服务于医院、门诊手术中心和导管室，主要用于治疗股腘动脉和膝下动脉病变。全球 PAD 负担的日益加重、球囊设计和药物涂层技术的进步以及对微创治疗的日益偏好，正在推动市场扩张。

市场驱动因素：

全球週边药物释放型球囊市场受多种关键因素驱动，包括人口老化导致周边动脉疾病盛行率上升，以及糖尿病和吸烟率上升。药物涂层技术（例如基于紫杉醇和Sirolimus的製剂）的进步显着改善了临床疗效，推动了其在医疗保健领域的应用。对微创且经济高效的支架替代方案的需求日益增长，也推动了市场成长。此外，已开发国家优惠的报销政策以及人们对週边动脉疾病（PAD）及其治疗方案日益增长的认识，进一步推动了新兴国家对置入术球囊（DEB）的需求。

市场限制：

儘管市场成长潜力巨大，产品核可仍面临严格的监管要求，尤其是在药物涂层的安全性和有效性方面。近期关于紫杉醇涂层器械及其长期安全性的争议引发了临床医生和监管机构的担忧，影响了其采用率。此外，这些器械的高昂成本以及开发中地区报销额度的有限性限制了其广泛应用。此外，裸球囊和支架等替代治疗方法的存在也加剧了市场竞争压力。

市场机会

週边药物释放型球囊市场蕴含着巨大的机会，这得益于涂层技术的创新、新兴市场的拓展以及与影像和导航技术的集成，从而改善了治疗效果。开发具有更优药物释放特性和更高生物相容性的下一代DEB球囊将抓住新的需求。临床试验投资的增加以及与研究机构的合作预计将提供可靠的数据，以支持更广泛的临床应用。此外，亚太和拉丁美洲医疗基础设施的成长将为市场渗透和成长开闢新的途径。

本报告探讨的关键问题

  • 推动全球週边药物释放型球囊市场成长的关键因素有哪些？
  • 哪些药物类型和解剖用途影响产品的开发和采用？
  • 法律规范和安全问题如何影响市场趋势和临床使用？
  • 外围 DEB 市场的主要企业是谁？他们采取什么策略来加强其竞争地位？
  • 每个地区的新兴趋势和长期成长前景如何？

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 价值链分析
  • 宏观经济因素
    • 世界GDP展望
    • 全球建设产业概况
    • 全球采矿业概况
  • 预测因子－相关性和影响力
  • COVID-19影响评估
  • PESTLE分析
  • 波特五力分析
  • 地缘政治紧张局势：市场影响
  • 监管和技术格局

第三章 市场动态

  • 驱动程式
  • 抑制因素
  • 机会
  • 趋势

第四章 2019-2032年价格趋势分析

  • 区域价格分析
  • 按细分市场定价
  • 价格影响因素

第五章全球週边药物释放型球囊市场展望：实际结果（2019-2024 年）与预测（2025-2032 年）

  • 主要亮点
  • 全球週边药物释放型球囊市场展望：药物涂层
    • 简介/主要发现
    • 2019-2024年医药包衣类型市场规模趋势分析
    • 2025 年至 2032 年药物涂层市场规模预测
      • 紫杉醇药物涂层
      • Sirolimus药物涂层
    • 市场吸引力分析：医药涂料
  • 全球週边药物释放型球囊市场展望：适应症
    • 简介/主要发现
    • 2019 年至 2024 年按适应症分類的市场规模趋势分析
    • 2025 年至 2032 年按适应症分類的当前市场规模预测
      • 周边动脉疾病
      • 週边动脉瘤
      • 支架内血管再阻塞
    • 市场吸引力分析：迹象
  • 全球週边药物释放型球囊市场展望：动脉型
    • 简介/主要发现
    • 2019-2024 年按主干道类型分類的市场规模趋势
    • 2025 年至 2032 年按主干道类型分類的当前市场规模预测
      • 颈动脉
      • Fempop 动脉
      • 髂动脉
      • 基础设施流行动脉
    • 市场吸引力分析：动脉类型
  • 全球週边药物释放型球囊市场展望：最终用户
    • 简介/主要发现
    • 2019-2024 年最终用户市场规模趋势分析
    • 2025 年至 2032 年按最终用户分類的当前市场规模预测
      • 医院
      • 门诊手术中心/门诊病人
      • 心导管实验室
    • 市场吸引力分析：最终用户

6. 全球週边药物释放型球囊市场（依地区）展望

  • 主要亮点
  • 2019-2024年区域市场规模趋势分析
  • 2025 年至 2032 年各地区目前市场规模预测
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：地区

第七章。北美週边药物释放型球囊市场展望：实际结果（2019-2024 年）与预测（2025-2032 年）

8. 欧洲週边药物释放型球囊市场展望：实际结果（2019-2024 年）与预测（2025-2032 年）

第九章东亚週边药物释放型球囊市场展望：实际结果（2019-2024 年）和预测（2025-2032 年）

第 10 章。南亚和大洋洲外周药物释放型球囊市场展望：实际结果（2019-2024 年）和预测（2025-2032 年）

第 11 章拉丁美洲週边药物释放型球囊市场展望：实际结果（2019-2024 年）和预测（2025-2032 年）

第 12 章。中东和非洲週边药物释放型球囊市场展望：实际结果（2019-2024 年）和预测（2025-2032 年）

第十三章竞争格局

  • 2025年市场占有率分析
  • 市场结构
    • 竞赛实力图谱
    • 竞争对手仪表板
  • 公司简介
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Cook Medical Inc.
    • MicroPort Scientific Corporation（Endovastec（TM））
    • Medtronic Plc.
    • Cardinal Health, Inc.
    • B. Braun Melsungen AG
    • BIOTRONIK SE &Co. KG
    • Becton, Dickinson and Company
    • WL Gore &Associates Inc.
    • Getinge AB
    • Terumo Corp
    • Kyoto Medical Planning Co Ltd
    • iVascular SLU
    • AMG International GmbH

第十四章 附录

  • 调查方法
  • 调查前提
  • 首字母缩写和简称
简介目录
Product Code: PMRREP27211

Persistence Market Research has recently released a comprehensive report on the worldwide market for peripheral drug eluting balloons. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Peripheral Drug Eluting Balloons Market Size (2025E): USD 1035.2 Million
  • Projected Market Value (2032F): USD 1,844.3 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 8.6%

Peripheral Drug Eluting Balloons Market - Report Scope:

Peripheral drug eluting balloons (DEBs) are medical devices used to treat peripheral arterial disease (PAD) by delivering anti-restenotic drugs directly to the arterial walls during angioplasty. These devices combine the mechanical benefits of balloon angioplasty with the pharmacological advantages of drug delivery, reducing the incidence of restenosis and eliminating the need for permanent implants. The market serves hospitals, ambulatory surgical centers, and catheterization labs, with applications primarily in the treatment of femoropopliteal and below-the-knee arterial lesions. Market expansion is driven by the increasing global burden of PAD, technological improvements in balloon design and drug coatings, and growing preference for minimally invasive procedures.

Market Growth Drivers:

The global peripheral drug eluting balloons market is propelled by several key factors, including the rising prevalence of peripheral arterial disease due to aging populations and increasing incidences of diabetes and smoking. Advancements in drug coating technologies, such as paclitaxel and sirolimus-based formulations, have significantly improved clinical outcomes, supporting adoption across healthcare settings. The growing demand for minimally invasive and cost-effective alternatives to stenting also boosts market growth. Additionally, favorable reimbursement policies in developed countries and a rise in awareness about PAD and its treatment options further fuel demand for DEBs.

Market Restraints:

Despite strong growth potential, the market faces challenges including stringent regulatory requirements for product approvals, particularly concerning the safety and efficacy of drug coatings. Recent controversies over paclitaxel-coated devices and their long-term safety have raised concerns among clinicians and regulatory bodies, impacting adoption rates. Moreover, high device costs and limited reimbursement in developing regions restrict widespread use. The presence of alternative treatment modalities, such as bare balloons and stents, also poses competitive pressure on the market.

Market Opportunities:

The peripheral drug eluting balloons market presents significant opportunities driven by innovation in coating technologies, expansion into emerging markets, and integration with imaging and navigation technologies for enhanced procedural outcomes. Development of next-generation DEBs with improved drug release profiles and biocompatible materials can capture new demand. Increasing investment in clinical trials and collaboration with research institutions are expected to generate robust data supporting broader clinical use. Moreover, growing healthcare infrastructure in Asia-Pacific and Latin America opens new avenues for market penetration and growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the peripheral drug eluting balloons market globally?
  • Which drug types and anatomical applications are influencing product development and adoption?
  • How are regulatory frameworks and safety concerns shaping market trends and clinical usage?
  • Who are the leading companies in the peripheral DEBs market, and what strategies are they employing to strengthen their competitive positioning?
  • What are the emerging trends and long-term growth prospects across different regions?

Competitive Intelligence and Business Strategy:

These companies are investing in the development of new drug formulations, biodegradable coatings, and balloons with improved deliverability and precision. Collaborations with academic institutions and clinical centers enable real-world validation and product optimization. Expansion into emerging markets through distribution agreements and regulatory approvals plays a critical role in capturing untapped demand and diversifying revenue streams.

Key Companies Profiled:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • MicroPort Scientific Corporation (Endovastec(TM))
  • Medtronic Plc.
  • Cardinal Health, Inc.
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Becton, Dickinson and Company
  • W. L. Gore & Associates Inc.
  • Getinge AB
  • Terumo Corp
  • Kyoto Medical Planning Co Ltd
  • iVascular S.L.U
  • AMG International GmbH
  • ENDOCOR GmbH
  • Meril Life Sciences Pvt. Ltd.
  • Nano Therapeutics Pvt Ltd
  • Koninklijke Philips N.V.
  • REVA Medical

Peripheral Drug Eluting Balloons Market Research Segmentation:

Drug Coating:

  • Paclitaxel Drug Coating
  • Sirolimus drug Coating
  • Others

Indication:

  • Peripheral Arterial Disease
  • Peripheral Aneurysms
  • In-Stent Restenosis
  • Others

Artery Type:

  • Carotid Arteries
  • Fem-Pop Arteries
  • Iliac Arteries
  • Infrapop Arteries

End User:

  • Hospitals
  • Ambulatory Surgical Centers/Outpatients
  • Cardiac Catheterization Labs

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Peripheral Drug Eluting Balloons Market Snapshot 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Industry Developments and Key Market Events
  • 1.5. Demand Side and Supply Side Analysis
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definitions
  • 2.2. Value Chain Analysis
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Outlook
    • 2.3.2. Global Construction Industry Overview
    • 2.3.3. Global Mining Industry Overview
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. COVID-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter's Five Forces Analysis
  • 2.8. Geopolitical Tensions: Market Impact
  • 2.9. Regulatory and Technology Landscape

3. Market Dynamics

  • 3.1. Drivers
  • 3.2. Restraints
  • 3.3. Opportunities
  • 3.4. Trends

4. Price Trend Analysis, 2019-2032

  • 4.1. Region-wise Price Analysis
  • 4.2. Price by Segments
  • 4.3. Price Impact Factors

5. Global Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 5.1. Key Highlights
  • 5.2. Global Peripheral Drug Eluting Balloons Market Outlook: Drug Coating
    • 5.2.1. Introduction/Key Findings
    • 5.2.2. Historical Market Size (US$ Mn) Analysis by Drug Coating, 2019-2024
    • 5.2.3. Current Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
      • 5.2.3.1. Paclitaxel Drug Coating
      • 5.2.3.2. Sirolimus drug Coating
    • 5.2.4. Market Attractiveness Analysis: Drug Coating
  • 5.3. Global Peripheral Drug Eluting Balloons Market Outlook: Indication
    • 5.3.1. Introduction/Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) Analysis by Indication, 2019-2024
    • 5.3.3. Current Market Size (US$ Mn) Forecast, by Indication, 2025-2032
      • 5.3.3.1. Peripheral Arterial Disease
      • 5.3.3.2. Peripheral Aneurysms
      • 5.3.3.3. In-Stent Restenosis
    • 5.3.4. Market Attractiveness Analysis: Indication
  • 5.4. Global Peripheral Drug Eluting Balloons Market Outlook: Artery Type
    • 5.4.1. Introduction/Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis by Artery Type, 2019-2024
    • 5.4.3. Current Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
      • 5.4.3.1. Carotid Arteries
      • 5.4.3.2. Fem-Pop Arteries
      • 5.4.3.3. Iliac Arteries
      • 5.4.3.4. Infrapop Arteries
    • 5.4.4. Market Attractiveness Analysis: Artery Type
  • 5.5. Global Peripheral Drug Eluting Balloons Market Outlook: End User
    • 5.5.1. Introduction/Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2024
    • 5.5.3. Current Market Size (US$ Mn) Forecast, by End User, 2025-2032
      • 5.5.3.1. Hospitals
      • 5.5.3.2. Ambulatory Surgical Centers/Outpatients
      • 5.5.3.3. Cardiac Catheterization Labs
    • 5.5.4. Market Attractiveness Analysis: End User

6. Global Peripheral Drug Eluting Balloons Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
  • 6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia & Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. North America Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
    • 7.4.1. Paclitaxel Drug Coating
    • 7.4.2. Sirolimus drug Coating
  • 7.5. North America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 7.5.1. Peripheral Arterial Disease
    • 7.5.2. Peripheral Aneurysms
    • 7.5.3. In-Stent Restenosis
  • 7.6. North America Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
    • 7.6.1. Carotid Arteries
    • 7.6.2. Fem-Pop Arteries
    • 7.6.3. Iliac Arteries
    • 7.6.4. Infrapop Arteries
  • 7.7. North America Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 7.7.1. Hospitals
    • 7.7.2. Ambulatory Surgical Centers/Outpatients
    • 7.7.3. Cardiac Catheterization Labs

8. Europe Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. Italy
    • 8.3.3. France
    • 8.3.4. U.K.
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Rest of Europe
  • 8.4. Europe Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
    • 8.4.1. Paclitaxel Drug Coating
    • 8.4.2. Sirolimus drug Coating
  • 8.5. Europe Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 8.5.1. Peripheral Arterial Disease
    • 8.5.2. Peripheral Aneurysms
    • 8.5.3. In-Stent Restenosis
  • 8.6. Europe Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
    • 8.6.1. Carotid Arteries
    • 8.6.2. Fem-Pop Arteries
    • 8.6.3. Iliac Arteries
    • 8.6.4. Infrapop Arteries
  • 8.7. Europe Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 8.7.1. Hospitals
    • 8.7.2. Ambulatory Surgical Centers/Outpatients
    • 8.7.3. Cardiac Catheterization Labs

9. East Asia Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. East Asia Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
    • 9.4.1. Paclitaxel Drug Coating
    • 9.4.2. Sirolimus drug Coating
  • 9.5. East Asia Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 9.5.1. Peripheral Arterial Disease
    • 9.5.2. Peripheral Aneurysms
    • 9.5.3. In-Stent Restenosis
  • 9.6. East Asia Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
    • 9.6.1. Carotid Arteries
    • 9.6.2. Fem-Pop Arteries
    • 9.6.3. Iliac Arteries
    • 9.6.4. Infrapop Arteries
  • 9.7. East Asia Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 9.7.1. Hospitals
    • 9.7.2. Ambulatory Surgical Centers/Outpatients
    • 9.7.3. Cardiac Catheterization Labs

10. South Asia & Oceania Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of SAO
  • 10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
    • 10.4.1. Paclitaxel Drug Coating
    • 10.4.2. Sirolimus drug Coating
  • 10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 10.5.1. Peripheral Arterial Disease
    • 10.5.2. Peripheral Aneurysms
    • 10.5.3. In-Stent Restenosis
  • 10.6. South Asia & Oceania Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
    • 10.6.1. Carotid Arteries
    • 10.6.2. Fem-Pop Arteries
    • 10.6.3. Iliac Arteries
    • 10.6.4. Infrapop Arteries
  • 10.7. South Asia & Oceania Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 10.7.1. Hospitals
    • 10.7.2. Ambulatory Surgical Centers/Outpatients
    • 10.7.3. Cardiac Catheterization Labs

11. Latin America Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of LATAM
  • 11.4. Latin America Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
    • 11.4.1. Paclitaxel Drug Coating
    • 11.4.2. Sirolimus drug Coating
  • 11.5. Latin America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 11.5.1. Peripheral Arterial Disease
    • 11.5.2. Peripheral Aneurysms
    • 11.5.3. In-Stent Restenosis
  • 11.6. Latin America Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
    • 11.6.1. Carotid Arteries
    • 11.6.2. Fem-Pop Arteries
    • 11.6.3. Iliac Arteries
    • 11.6.4. Infrapop Arteries
  • 11.7. Latin America Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 11.7.1. Hospitals
    • 11.7.2. Ambulatory Surgical Centers/Outpatients
    • 11.7.3. Cardiac Catheterization Labs

12. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. South Africa
    • 12.3.3. Northern Africa
    • 12.3.4. Rest of MEA
  • 12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
    • 12.4.1. Paclitaxel Drug Coating
    • 12.4.2. Sirolimus drug Coating
  • 12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 12.5.1. Peripheral Arterial Disease
    • 12.5.2. Peripheral Aneurysms
    • 12.5.3. In-Stent Restenosis
  • 12.6. Middle East & Africa Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
    • 12.6.1. Carotid Arteries
    • 12.6.2. Fem-Pop Arteries
    • 12.6.3. Iliac Arteries
    • 12.6.4. Infrapop Arteries
  • 12.7. Middle East & Africa Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 12.7.1. Hospitals
    • 12.7.2. Ambulatory Surgical Centers/Outpatients
    • 12.7.3. Cardiac Catheterization Labs

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles
    • 13.3.1. Abbott Laboratories
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Product Portfolio/Offerings
      • 13.3.1.3. Key Financials
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Company Strategy and Key Developments
    • 13.3.2. Boston Scientific Corporation
    • 13.3.3. Cook Medical Inc.
    • 13.3.4. MicroPort Scientific Corporation (Endovastec(TM))
    • 13.3.5. Medtronic Plc.
    • 13.3.6. Cardinal Health, Inc.
    • 13.3.7. B. Braun Melsungen AG
    • 13.3.8. BIOTRONIK SE & Co. KG
    • 13.3.9. Becton, Dickinson and Company
    • 13.3.10. W. L. Gore & Associates Inc.
    • 13.3.11. Getinge AB
    • 13.3.12. Terumo Corp
    • 13.3.13. Kyoto Medical Planning Co Ltd
    • 13.3.14. iVascular S.L.U
    • 13.3.15. AMG International GmbH

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations